Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 28, 2017; 23(40): 7274-7282
Published online Oct 28, 2017. doi: 10.3748/wjg.v23.i40.7274
Table 1 Patient Characteristics n (%)
Caucasian (n = 137)Latino (n = 64)All Patients (n = 201)P value
Age of presentation with AH (yr)0.082
mean ± SD49.5 (10.4)46.8 (10.1)48.6 (10.4)
Sex0.049
Male77 (56.2)46 (71.9)123 (61.2)
Female60 (43.8)18 (28.1)78 (38.8)
BMI0.167
mean ± SD28.1 (5.9)29.4 (6.2)28.5 (6)
DM0.061
No105 (76.6)41 (64.1)146 (72.6)
Yes25 (18.2)20 (31.2)45 (22.4)
Unknown7 (5.1)3 (4.7)10 (5)
Metabolic syndrome0.405
No37 (27)13 (20.3)50 (24.9)
Yes53 (38.7)28 (43.8)81 (40.3)
Unknown47 (34.3)23 (35.9)70 (34.8)
Duration of drinking (yr)0.027
mean ± SD20 (12.7)24.3 (11)21.6 (12.3)
Pattern of drinking0.283
Heavy drinking5 (3.6)05 (2.5)
Binge drinking130 (94.9)64 (100.0)194 (96.5)
Unknown2 (1.5)02 (1.0)
Number of drinks/d0.093
mean ± SD13.9 (10.9)16.1 (7.2)14.6 (9.9)
None100 (73.0)37 (57.8)137 (68.2)
Cocaine2 (1.5)02 (1.0)
Heroin1 (0.7)01 (0.5)
Methamphetamine1 (0.7)8 (12.5)9 (4.5)
Marijuana9 (6.6)3 (4.7)12 (6.0)
Other2 (1.5)02 (1.0)
Polysubstance abuse10 (7.3)9 (14.1)19 (9.5)
Remote history6 (4.4)6 (9.4)12 (6.0)
Unknown6 (4.4)1 (1.6)7 (3.5)